Marc Suárez-Calvet

Biomarkers for risk assessment and early diagnosis of AD

Next steps in dementia biomarkers

What do we understand about the secretion of brain p-tau in AD?

Blood p-tau in symptomatic and non-symptomatic AD patients

Importance of standardizing biomarker protocols in the diagnosis of AD

Head-to-head comparison of p-tau species for Alzheimer’s disease detection in a real-world cohort